Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 267.40
Bid: 267.50
Ask: 267.90
Change: 3.30 (1.25%)
Spread: 0.40 (0.15%)
Open: 265.40
High: 268.40
Low: 264.40
Prev. Close: 264.10
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

5 Aug 2022 17:51

RNS Number : 1595V
Man Group plc
05 August 2022
 

Transactions in own shares

 

Man Group plc (the "Company") announces that it has purchased the following number of its ordinary shares of 3 3/7 US cents on the London Stock Exchange as part of its US$125 million share buyback programme announced on 30 June 2022.

 

Date of purchase:

5 August 2022

 

Number of ordinary shares purchased:

900,068

 

Time of transaction:

8:00 to 16:30

 

Highest price per share:

242.9000

 

Lowest price per share:

238.9000

 

Weighted average price per share:

241.3643

 

The Company intends to hold the purchased shares in treasury. Following the purchase and settlement of these shares, the Company will hold 110,490,134 of its ordinary shares in treasury and will have 1,304,282,610 ordinary shares in issue (excluding treasury shares).

 

Since the commencement of the share repurchase programme, the Company has repurchased 17,088,456 ordinary shares in aggregate at a weighted average price of 250.4648 pence per share.

 

All transactions under this programme will be published on the Company's website (www.man.com) on a weekly basis.

 

The table below contains detailed information about the purchases made as part of the buyback programme.

 

Schedule of Purchases

 

Shares purchased: 900,068 (ISIN: JE00BJ1DLW90)

 

Date of purchases: 5 August 2022

 

Investment firm: J.P. Morgan Securities plc

 

Aggregated information:

 

Venue

Lowest price per share

Highest price per share

London Stock Exchange

238.9000

242.9000

BATS Europe

-

-

 

Enquiries

Karan Shirgaokar

Director, Investor Relations

+44 (0)20 7144 1434

investor.relations@man.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUPUBCRUPPGQA
Date   Source Headline
4th Nov 20215:58 pmRNSTransaction in Own Shares
3rd Nov 20216:01 pmRNSTransaction in Own Shares
2nd Nov 20215:54 pmRNSTransaction in Own Shares
1st Nov 20216:04 pmRNSTransaction in Own Shares
1st Nov 20217:00 amRNSTotal Voting Rights
29th Oct 20215:41 pmRNSTransaction in Own Shares
28th Oct 20215:48 pmRNSTransaction in Own Shares
27th Oct 20216:15 pmRNSTransaction in Own Shares
26th Oct 20216:08 pmRNSTransaction in Own Shares
25th Oct 20215:57 pmRNSTransaction in Own Shares
22nd Oct 20216:07 pmRNSTransaction in Own Shares
22nd Oct 20213:50 pmRNSTreasury Shares Cancellation & Total Voting Rights
21st Oct 20215:37 pmRNSTransaction in Own Shares
21st Oct 20213:30 pmRNSHolding(s) in Company
20th Oct 20216:11 pmRNSTransaction in Own Shares
19th Oct 20215:48 pmRNSTransaction in Own Shares
18th Oct 20215:58 pmRNSTransaction in Own Shares
15th Oct 20215:41 pmRNSTransaction in Own Shares
14th Oct 20216:23 pmRNSTransaction in Own Shares
13th Oct 20216:03 pmRNSTransaction in Own Shares
13th Oct 20217:00 amRNSTrading Statement - Q3 2021
12th Oct 20215:12 pmRNSTransaction in Own Shares
11th Oct 20215:38 pmRNSTransaction in Own Shares
8th Oct 20215:57 pmRNSTransaction in Own Shares
7th Oct 20215:54 pmRNSTransaction in Own Shares
6th Oct 20216:03 pmRNSTransaction in Own Shares
5th Oct 20216:02 pmRNSTransaction in Own Shares
5th Oct 20217:00 amRNSTransaction in Own Shares
1st Oct 20216:03 pmRNSTransaction in Own Shares
1st Oct 20217:00 amRNSTotal Voting Rights
30th Sep 20215:52 pmRNSTransaction in Own Shares
29th Sep 20216:05 pmRNSTransaction in Own Shares
28th Sep 20216:07 pmRNSTransaction in Own Shares
27th Sep 20215:50 pmRNSTransaction in Own Shares
24th Sep 20216:06 pmRNSTransaction in Own Shares
23rd Sep 20215:49 pmRNSTransaction in Own Shares
22nd Sep 202110:13 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
22nd Sep 202110:06 amGNWMan Group PLC : Form 8.3 - John Laing Group plc
21st Sep 20215:47 pmRNSTransaction in Own Shares
21st Sep 20219:19 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Sep 20215:41 pmRNSTransaction in Own Shares
17th Sep 20215:54 pmRNSTransaction in Own Shares
17th Sep 20213:00 pmRNSDirectorate Change
16th Sep 20215:52 pmRNSTransaction in Own Shares
15th Sep 20216:16 pmRNSTransaction in Own Shares
15th Sep 202111:14 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
14th Sep 20215:52 pmRNSTransaction in Own Shares
14th Sep 20211:56 pmRNSMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Sep 20215:51 pmRNSTransaction in Own Shares
13th Sep 202112:15 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.